Joseph Ciccolini Email & Phone Number

Bruxelles Et Périphérie

PAMM-EORTC

Région De Marseille, France

Senior Lecturer in Pharmacokinetics, Pharmacogenetics & Translational oncology.

Marseille, Provence-Alpes-Côte D’Azur, France

DIGIPHARM (Digital Tools for Pharmaceutical Sciences) is a research-based and project-based Master Degree focusing on coding and programming languages dedicated to pharmaceutical sciences.

Co-Head of the COMPO team (Computational Oncology & Clinical Pharmacology), an Inserm-INRIA joint team at the Centre de Recherche en Cancérologie de Marseille (CRCM, Inserm U1068). COMPO is dedicated to developing algorithm-based and modeling tools to improve the clinical outcome in patients with cancer following three main axes: quantitative modeling for personalized clinical oncology, individualizing drug regimens and optimizing combinatorial strategies with immune checkpoint inhibitors.

Marseille, Provence-Alpes-Côte D’Azur, France

Head of the platform in Pharmacokinetics of the CRCM (Inserm U1068) - Translational research in PK and PK/PD of anticancer agents with a focus on improving PK through developing drug delivery systems and testing new algorithms-driven combinatorial strategies with immuno-oncology drugs.

South Of France & Corsica

Independent beekeeper and honey-maker at Miel de la Soupriote in south-of-France (Buckfast strain, mostly lime-blossom and lavender honey) and Mele di Sarbaghjonu in Corsica (Apis mellifera mellifera corsica strain, mostly chestnut honey).

University Hospital Of Marseille

Clinical Pharmacokinetics in Oncology & Pharmacogenetics:Anticancer drugs pharmacokinetics and pharmacogenetics. This, includes developing new adaptive dosing strategies and biomarker-based medicine in oncology as a means to optimize the efficacy/toxicity balance of anticancer drugs at bedside (i.e., cytotoxics, targeted therapies, biologics, immune checkpoint inhibitors).

Playing Good Cop, Bad Cop

Région De Bruxelles-Capitale, Belgique

The PAMM is the Pharmacology group of the European Organization of Research and Treatment for Cancer (EORTC) and aims at promoting the fields of PK, PGx, and pharmacometrics in experimental and clinical oncology.

Bruxelles, Région De Bruxelles-Capitale, Belgique

Italy

Lecturer in Pharmacokinetics and Pharmacometrics applied to metronomic chemotherapy.

Marseille, Ufr Pharmacie, France.

Experimental Therapeutics in Oncology & Pharmacokinetics at EA3286 then CRO2 Inserm U911 then Centre de Recherche en Cancérologie de Marseille (CRCM), UMR Inserm U1068: Group Leader of the Experimental & Translationnal PK Dept of the Pharmacokinetics Laboratory of Aix Marseille Univ. Translational research focused on anticancer agents, either cytotoxics, targeted therapies or biologics. Non-clinical activities include testing novel combinational therapies and/or innovative modalities of administration (e.g., metronomic chemotherapies, new drug delivery systems), both in vitro and in tumor-bearing animals, using state-of-the-art 3D imaging techniques. Experimental data generated for the Modeling & Simulation group (SMARTc) as part of Mathematical Oncology global project of the CRCM research unit. Other non-clinical activities include DM-PK and animal/experimental pharmacokinetics studies. Lecturing: Head of the M.Sc. in Pharmacokinetics (M2RPK) of the Aix Marseille University since 2008.Additional lecturing activities include teaching Fundamental & Clinical Pharmacokinetics and Oncology Therapeutics at the School of Pharmacy of Marseille, as well as Anticancer Drugs Pharmacogenetics as part of the M.Sc. in Genetics of the Aix Marseille University, Anticancer Drugs Pharmacokinetics as part of the M.Sc. BIP of University Pierre et Marie Curie (UPMC, Paris VI), Pharmacogenetics as part M.Sc in Biomedicine of the Université de Montpellier II, and Pharmacogenetics as part of the joint M.Sc. in Biobanking of the University of Nice and Université Catholique de Lyon (ESTBB).

Région De Paris, France

The Groupe de Pharmacologie Clinique et Oncologique is affiliated to the french Unicancer network and is committed to promoting pharmacokinetics and pharmacogenetics in clinical oncology.

Marseille, Provence-Alpes-Côte D’Azur, France

The M2RPK (Master Degree in Pharmacokinetics) of Aix-Marseille Univ, Marseille France offers a unique mix of courses in modeling & simulation, experimental pharmacokinetics, clinical pharmacokinetics and bioanalysis.

Ea3286 Pharmacokinetics Unit, Marseille

Supervisor: Pr J. CatalinExperimental Therapeutics in Oncology & DMPK: development of pharmacomodulation and suicide-gene therapy strategies to improve the intratumoral activation of prodrug 5-FU and capecitabine into active metabolites in colorectal cancer models.

Hitchin Hertsfordshire, Uk

R&D facility: Analytical Development as part of IND application for an innovative dry-powder inhaler device.

Orléans, France

M.Sc. student in training - Animal Pharmacokinetics Division. Development of microdialysis-based sampling in animal pharmacokinetics studies (rodents).

Clinical Pharmacokinetics Unit - La Timone University Hospital Of Marseille

Population pharmacokinetics-based approach for developing adaptive dosing strategies of high-dose methotrexate in patients with osteosarcoma.

Hdr (Habilitation À Diriger Les Recherches) - French Accreditation To Supervise Research, (A.K.A. Tenure)

Doctor Of Philosophy (Ph.D.), Pharmacokinetics

Accreditation To Perform Animal Studies In Pharmacokinetics.

M.Sc., Pharmacokinetics

Doctor Of Pharmacy (Pharm.D.)